Consolidated Portfolio Review Corp Elevance Health, Inc. Transaction History
Consolidated Portfolio Review Corp
- $632 Billion
- Q4 2024
A detailed history of Consolidated Portfolio Review Corp transactions in Elevance Health, Inc. stock. As of the latest transaction made, Consolidated Portfolio Review Corp holds 593 shares of ELV stock, worth $238,842. This represents 0.03% of its overall portfolio holdings.
Number of Shares
593Holding current value
$238,842% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding ELV
# of Institutions
1,799Shares Held
206MCall Options Held
1.53MPut Options Held
1.37M-
Vanguard Group Inc Valley Forge, PA21.5MShares$8.65 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY20.7MShares$8.34 Billion0.26% of portfolio
-
State Street Corp Boston, MA10.7MShares$4.3 Billion0.16% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$4.28 Billion0.45% of portfolio
-
Wellington Management Group LLP Boston, MA6.36MShares$2.56 Billion0.44% of portfolio
About Elevance Health, Inc.
- Ticker ELV
- Exchange NYSE
- Sector Healthcare
- Industry Healthcare Plans
- Shares Outstandng 240,000,992
- Market Cap $96.7B
- Description
- Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....